Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: PROF

Profound Medical Corp.

Healthcare | Medical - Devices

No licensed closing price on file for PROF. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2025)$1.41

Profound Medical Corp. (NASDAQ: PROF) is a medical device company. Figures from SEC EDGAR; updated 2026-10-21 06:03 UTC.

What Profound Medical Corp. does

The company develops and markets AI-powered, MRI-guided systems that use focused ultrasound to ablate diseased tissue without surgical incisions. Its lead product, TULSA-PRO, combines real-time MRI imaging with robotically-driven ultrasound and temperature feedback to treat prostate cancer and benign prostatic hyperplasia; it received FDA clearance in the United States, CE marking in the EU, and approval in Canada. A second system, Sonalleve, is approved in multiple regions for treating uterine fibroids, bone metastases, osteoid osteoma, and desmoid tumors.

Summarized from Profound Medical Corp.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (FY2025)$1.41
Return on equity-64.08%
Debt/equity0.08

Revenue, margins & earnings

FY2023: net loss $28M on revenue $7M$7MFY2023FY2024: net loss $28M on revenue $11M$11MFY2024FY2025: net loss $43M on revenue $16M$16MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2025-05-20
Most recent filed transactions — May 2025:
  • 2025-05-20CEOPurchase10,003$43.3K
  • 2025-05-20CEOPurchase12,027$56.9K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Profound Medical Corp. do?

The company develops and markets AI-powered, MRI-guided systems that use focused ultrasound to ablate diseased tissue without surgical incisions.

When did PROF last file with the SEC?

Profound Medical Corp.'s most recent SEC filing on record is a 8-K filed 2026-10-14. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 06:03 UTC. This page is also available as JSON at /api/data?ticker=PROF and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for PROF and 5,000+ tickers.

Create a free account — keep PROF
For your agent
GET /api/data?ticker=PROF

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt